The agent successfully assembled a comprehensive explanation of PiaSky's purpose, target audience, key differentiators, and limitations by fetching the homepage and three content pages from the site itself. The website was moderately navigable—the agent found core positioning and clinical information through direct fetches and web search discovery, but pricing information was entirely absent, requiring the agent to explicitly flag this gap. The site's dynamic rendering (JavaScript-heavy) and HCP-gated positioning limited how much content was machine-readable in the raw HTML.

• ›Step [1] (homepage) established the product category (C5 inhibitor for PNH) and provided the foundational meta description; steps [5], [6], [7] returned content pages covering differentiators (why-piasky), clinical mechanism (c5-inhibitors-and-pnh), and efficacy claims—these were the core sources for the final answer.
• ›The agent discovered content pages via web search results (step [4]), not by crawling site navigation—suggesting the site's internal link structure was either not machine-readable or not exposed in the static HTML returned. The agent had to rely on prior knowledge and external search to route between pages.
• ›Pricing information was completely absent from the site despite being a central business question. The agent noted this explicitly and identified it as a typical gap for global HCP-focused pharma sites, suggesting it assembled this insight from prior knowledge rather than site content.
• ›The site enforces an HCP access gate and explicitly excludes US/UK audiences; this positioning constraint was clearly communicated in meta tags but limits the agent's ability to extract full prescribing and market information from a single domain.
• ›The HTML responses were truncated ("[truncated, 4400 more chars]"), indicating substantial JavaScript-rendered content was not included in the fetches, reducing the agent's visibility into the full page content and potentially missing detailed comparisons or clinical data.